Onward Medical N.V.
ONWRF
$5.70
-$0.42-6.86%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.84% | -23.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.84% | -23.59% | |||
| Cost of Revenue | 7.85% | -17.57% | |||
| Gross Profit | -7.85% | 15.95% | |||
| SG&A Expenses | 7.85% | 42.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.85% | 18.50% | |||
| Operating Income | -7.85% | -22.51% | |||
| Income Before Tax | -7.85% | -20.56% | |||
| Income Tax Expenses | 7.81% | -36.10% | |||
| Earnings from Continuing Operations | -7.85% | -19.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.85% | -19.66% | |||
| EBIT | -7.85% | -22.51% | |||
| EBITDA | -7.85% | -20.91% | |||
| EPS Basic | -7.85% | -46.39% | |||
| Normalized Basic EPS | -7.82% | -47.61% | |||
| EPS Diluted | -7.85% | -46.39% | |||
| Normalized Diluted EPS | -7.82% | -47.61% | |||
| Average Basic Shares Outstanding | 0.00% | -18.29% | |||
| Average Diluted Shares Outstanding | 0.00% | -18.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||